A process of compensation (or redundancy) displayed by other PGs expression in the present model could explain the absence of a SDC-1 specific effect, as it has been reported in the context of atherosclerosis between biglycan and perlecan for Apo-B retention (46). This evidence concerns the gene HSPG2 and atherosclerosis.